You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.
Isaac “Zak” Kohane is the chair of biomedical informatics at Harvard Medical…
Article Source
https://www.statnews.com/2025/04/16/nejm-editor-chief-fda-approval-vs-clinical-effectiveness-ai-prognosis/